Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities

Disparity in Depression Treatment Among Racial and Ethnic Minority Populations in the United States

(2015) Margarita Alegría et al.   PSYCHIATRIC SERVICES

Racial and Ethnic Disparities in Indicators of a Primary Care Medical Home for Children

(2009) Jean L. Raphael et al.   Academic Pediatrics

Racial and Ethnic Disparities in Pain: Causes and Consequences of Unequal Care

(2009) Karen O. Anderson et al.   JOURNAL OF PAIN

Adherence to Hydroxyurea Therapy in Children with Sickle Cell Anemia

(2009) Courtney D. Thornburg et al.   JOURNAL OF PEDIATRICS

Precaution, cyclooxygenase inhibition, and cardiovascular risk

(2009) James M. Ritter et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events

(2008) Amanda M. Brandow et al.   BRITISH JOURNAL OF HAEMATOLOGY

Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males

(2008) I. Berthaut et al.   HAEMATOLOGICA

Healthcare utilization and expenditures for low income children with sickle cell disease

(2008) Jean L. Raphael et al.   PEDIATRIC BLOOD & CANCER

Risk factors for hospital readmission within 30 days: A new quality measure for children with sickle cell disease

(2008) Melissa J. Frei-Jones et al.   PEDIATRIC BLOOD & CANCER

Hydroxyurea for Children with Sickle Cell Disease

(2008) Matthew M. Heeney et al.   PEDIATRIC CLINICS OF NORTH AMERICA